Workday Inc (WDAY) Holdings Increased by Qube Research & Technologies Ltd

Share on StockTwits

Qube Research & Technologies Ltd grew its holdings in shares of Workday Inc (NASDAQ:WDAY) by 201.6% in the second quarter, Holdings Channel reports. The institutional investor owned 2,561 shares of the software maker’s stock after purchasing an additional 1,712 shares during the period. Qube Research & Technologies Ltd’s holdings in Workday were worth $310,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. The Manufacturers Life Insurance Company lifted its holdings in Workday by 1.3% during the 1st quarter. The Manufacturers Life Insurance Company now owns 3,090,009 shares of the software maker’s stock worth $392,772,000 after buying an additional 39,749 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Workday by 19.7% during the 1st quarter. Franklin Resources Inc. now owns 1,342,790 shares of the software maker’s stock worth $170,682,000 after buying an additional 220,640 shares during the last quarter. Federated Investors Inc. PA lifted its holdings in Workday by 22.3% during the 1st quarter. Federated Investors Inc. PA now owns 1,296,567 shares of the software maker’s stock worth $164,807,000 after buying an additional 236,811 shares during the last quarter. First Trust Advisors LP lifted its holdings in Workday by 43.3% during the 2nd quarter. First Trust Advisors LP now owns 989,908 shares of the software maker’s stock worth $119,898,000 after buying an additional 299,251 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in Workday by 5.0% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 676,374 shares of the software maker’s stock worth $81,922,000 after buying an additional 32,119 shares during the last quarter. 67.96% of the stock is owned by institutional investors.

Shares of WDAY stock opened at $151.07 on Friday. Workday Inc has a 52-week low of $95.35 and a 52-week high of $157.12. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.54.

Workday (NASDAQ:WDAY) last issued its quarterly earnings results on Tuesday, September 4th. The software maker reported $0.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.05. The firm had revenue of $671.70 million for the quarter, compared to analysts’ expectations of $663.38 million. Workday had a negative return on equity of 13.36% and a negative net margin of 13.81%. The firm’s revenue for the quarter was up 27.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.24 EPS. analysts anticipate that Workday Inc will post -1.12 earnings per share for the current year.

In other Workday news, Director David A. Duffield sold 392,758 shares of the business’s stock in a transaction that occurred on Monday, July 9th. The stock was sold at an average price of $127.34, for a total transaction of $50,013,803.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Michael M. Mcnamara sold 19,755 shares of the business’s stock in a transaction that occurred on Thursday, June 21st. The stock was sold at an average price of $128.05, for a total value of $2,529,627.75. The disclosure for this sale can be found here. Insiders sold a total of 532,371 shares of company stock worth $69,591,600 in the last 90 days. 33.59% of the stock is currently owned by insiders.

A number of analysts have issued reports on the company. JMP Securities decreased their price target on Workday from $175.00 to $152.95 and set an “outperform” rating for the company in a report on Wednesday, September 5th. They noted that the move was a valuation call. UBS Group boosted their target price on Workday to $145.00 and gave the company an “overweight” rating in a report on Friday, June 1st. Deutsche Bank boosted their target price on Workday from $115.00 to $140.00 and gave the company a “hold” rating in a report on Wednesday, September 5th. Monness Crespi & Hardt boosted their target price on Workday from $156.00 to $158.00 and gave the company a “buy” rating in a report on Friday, June 1st. Finally, Piper Jaffray Companies reissued an “overweight” rating and issued a $150.00 target price (up from $140.00) on shares of Workday in a report on Friday, June 1st. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $145.31.

About Workday

Workday, Inc provides enterprise cloud applications for finance and human resources worldwide. It provides applications for customers to manage critical business functions to optimize their financial and human capital resources. The company offers Workday Financial Management application that provides functions of general ledger, accounting, accounts payable and receivable, cash and asset management, employee expense and revenue management, projects, procurement, inventory, and grants management.

Read More: How is a Moving Average Calculated?

Want to see what other hedge funds are holding WDAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Workday Inc (NASDAQ:WDAY).

Institutional Ownership by Quarter for Workday (NASDAQ:WDAY)

Receive News & Ratings for Workday Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Workday and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Clorox  Stock Rating Upgraded by Argus
Clorox Stock Rating Upgraded by Argus
Advanced Micro Devices  Receives New Coverage from Analysts at KeyCorp
Advanced Micro Devices Receives New Coverage from Analysts at KeyCorp
Achillion Pharmaceuticals  Raised to Sell at BidaskClub
Achillion Pharmaceuticals Raised to Sell at BidaskClub
Holly Energy Partners  Downgraded to Underweight at Barclays
Holly Energy Partners Downgraded to Underweight at Barclays
Sierra Oncology  Stock Rating Upgraded by Zacks Investment Research
Sierra Oncology Stock Rating Upgraded by Zacks Investment Research
Traders Buy Shares of VanEck Vectors J.P. Morgan EM Local Currency Bond ETF  on Weakness
Traders Buy Shares of VanEck Vectors J.P. Morgan EM Local Currency Bond ETF on Weakness


Leave a Reply

 
© 2006-2018 Zolmax.